Extractables and Leachables Testing

Extractables and leachables (E&L) testing is a critical piece of regulatory strategy for drug products, biologics, and combination products — yet it's often treated as a late-stage compliance checkbox instead of an early risk-management tool. In this white paper, our CMC Analytical team breaks down a practical, science- and risk-based framework for designing, executing, and defending E&L programs from material selection through regulatory submission. Check it out to see how a well-structured E&L strategy can save you time, cost, and headaches down the road.

"*" indicates required fields

X/Twitter

This field is for validation purposes and should be left unchanged.

First Name*

Last Name*

Company*

State*